Arosa Capital Management LP Acquires Shares of 493,000 Mirion Technologies, Inc. (NYSE:MIR)

Arosa Capital Management LP acquired a new stake in Mirion Technologies, Inc. (NYSE:MIR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 493,000 shares of the company's stock, valued at approximately $8,603,000. Mirion Technologies makes up approximately 3.5% of Arosa Capital Management LP's investment portfolio, making the stock its 7th biggest holding. Arosa Capital Management LP owned 0.21% of Mirion Technologies as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MIR. US Bancorp DE grew its holdings in shares of Mirion Technologies by 3,248.7% in the 4th quarter. US Bancorp DE now owns 6,262 shares of the company's stock worth $109,000 after acquiring an additional 6,075 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of Mirion Technologies by 162.9% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock worth $116,000 after purchasing an additional 4,120 shares during the period. Harvest Fund Management Co. Ltd purchased a new stake in shares of Mirion Technologies in the fourth quarter valued at $120,000. KBC Group NV lifted its position in Mirion Technologies by 39.2% during the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock worth $140,000 after buying an additional 2,254 shares during the period. Finally, SkyView Investment Advisors LLC acquired a new stake in Mirion Technologies in the 3rd quarter worth about $111,000. Institutional investors and hedge funds own 78.51% of the company's stock.

Mirion Technologies Stock Up 2.6 %

Shares of NYSE:MIR traded up $0.42 during mid-day trading on Friday, hitting $16.17. 763,516 shares of the company traded hands, compared to its average volume of 1,670,529. The firm has a market cap of $3.76 billion, a P/E ratio of -85.08 and a beta of 0.75. Mirion Technologies, Inc. has a 52-week low of $9.11 and a 52-week high of $18.81. The firm's 50 day simple moving average is $14.48 and its 200 day simple moving average is $15.65. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.55 and a current ratio of 2.16.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The business had revenue of $202.00 million during the quarter, compared to the consensus estimate of $199.34 million. During the same period in the prior year, the firm earned $0.06 earnings per share. The business's quarterly revenue was up 4.9% compared to the same quarter last year. On average, equities analysts anticipate that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on MIR shares. Citigroup cut their target price on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Robert W. Baird cut their price objective on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, April 4th. Finally, B. Riley decreased their target price on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a report on Wednesday, April 16th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Mirion Technologies presently has a consensus rating of "Buy" and an average price target of $18.75.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.